fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Major cardio event risk among statin users associated with non-HDL-C level

Written by | 14 Jun 2012

Findings from a newly published meta-analysis suggests that levels of non-high-density lipoprotein cholesterol (non-HDL-C) among statin users is associated with risk of developing a major cardiovascular event, such… read more.

Abuse of opioid drugs linked to mood and anxiety disorders

Written by | 14 Jun 2012

Mood and anxiety disorders such as bipolar, panic disorder and major depressive disorder appear to be highly associated with non-medical prescription opioid use.

Little benefit in imaging tests for women with breast pain

Written by | 14 Jun 2012

by Bruce Sylvester – Women with breast pain who undergo extra-routine mammograms, MRIs or ultrasounds as part of breast pain evaluation derive no diagnostic or therapeutic benefit, researchers… read more.

Duloxetine appears to relieve chemotherapy-related neuropathic pain

Written by | 14 Jun 2012

Paper presented on 5th June at ASCO – by Bruce Sylvester – The antidepressant duloxetine (Cymbalta ®), relieves  neuropathic pain caused by chemotherapy in 59 percent of patients,… read more.

EASL 2012 Report – Anemia management in Hepatitis C patients

Written by | 14 Jun 2012

by Bruce Sylvester – Researchers from a Phase III study report no difference in rates of viral clearance between two anemia management strategies for patients with chronic hepatitis… read more.

EASL 2012 Report – EMERGE: Efficacy and safety in HCV of investigative pegylated interferon lambda-1a compared to standard interferon therapy

Written by | 14 Jun 2012

by Bruce Sylvester – Researchers report that patients with genotype 2 or 3 hepatitis C virus (HCV) treated with investigative pegylated interferon lambda-1a (peg-IFN-lambda 1a, Bristol-Myers Squibb) in… read more.

EASL 2012 Report – Europe bears high costs of chronic liver diseases and high mortality in cirrhosis

Written by | 14 Jun 2012

by Bruce Sylvester – Two studies presented at EASL suggest the real human and economic costs of liver disease across Europe.

Study reports increasing incidence of Clostridium difficile infection (C. diff)

Written by | 14 Jun 2012

C. difficile is a bacterium that is common in the environment. According to the Center for Disease Control and Prevention, approximately 337,000 cases of CDI are reported each… read more.

EASL 2012 Report – CO-PILOT: Emerging, investigative interferon-free HCV treatment

Written by | 14 Jun 2012

by Bruce Sylvester – Researchers report that combination  ABT-450 with ritonavir (ABT-450/r, Abbott) plus ABT-333 plus ribavirin (RBV) is both well tolerated and led to high sustained virological… read more.

Tocilizumab is more effective than adalimumab at reducing signs and symptoms of RA

Written by | 14 Jun 2012

Safety results were similar between groups. Data presented at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tocilizumab monotherapy is more effective than… read more.

Changes in smoking significantly impacts lung cancer mortality in the U.S. : 1975-2000

Written by | 14 Jun 2012

by Bruce Sylvester – Researchers report that, in the last quarter of the 20th century, changes in smoking behaviors have led to a significant drop in lung cancer… read more.

Opioids relieve severe shortness of breath in COPD

Written by | 14 Jun 2012

by Bruce Sylvester – Opioid treatment offers relief and improved quality of life to patients with advanced chronic obstructive pulmonary disease (COPD) and shortness of breath,

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.